Search results for "Ménétrier's disease"

showing 3 items of 3 documents

Case Report: Primary Peritonitis as the Onset of Pediatric Ménétriers Disease

2021

Introduction: Primary peritonitis (PP) and Ménétrier's Disease (MD) are both rare conditions among pediatric population. Although about 150 MD cases have been described in the scientific literature to date, its onset with a PP is an unusual condition.Case Presentation: We present a case of an 11-year-old boy who was admitted to our unit because of abdominal pain and distension. Complementary tests showed ascites, bilateral pleural effusion, leukocytosis, increased acute phase reactants and hypoproteinemia with hypoalbuminemia. Laparoscopy ruled out appendicitis or visceral perforations and exposed purulent peritoneal fluid, compatible with PP. Biochemical stool analysis showed increased cle…

Abdominal painmedicine.medical_specialtyPediatricsGastroenterology03 medical and health sciencesHypoproteinemia0302 clinical medicine030225 pediatricsInternal medicineMénétrier's diseaseAscitesmedicinecase reportEnteropathyHypoalbuminemiaprotein-losing enteropathybusiness.industryProtein losing enteropathylcsh:RJ1-570lcsh:Pediatricsmedicine.diseaseAppendicitisMénétrier's diseasehypertrophic gastropathyPediatrics Perinatology and Child Health030211 gastroenterology & hepatologymedicine.symptombusinessprimary peritonitisFrontiers in Pediatrics
researchProduct

Ménétrier's disease in a patient with refractory ulcerative colitis: a clinical challenge and review of the literature

2023

Ménétrier’s disease (MD) is a rare disease of the stomach, characterised by hypertrophic gastric folds leading to protein loss. The association with ulcerative colitis (UC) is rare but has been reported in the literature. We report a case of a 29-year-old male affected by UC with an additional diagnosis of MD 3 years after UC diagnosis. UC was refractory to several treatment lines (thiopurines, infliximab, vedolizumab and ustekinumab), and the patient underwent colectomy. Octreotide was administered for MD normalising blood biochemistry, but it was not effective in inducing endoscopic remission of the stomach. Treatment options in patients with MD and UC are discussed.

AdultMalemedicine.medical_specialtymedicine.medical_treatmentGastroenterologyInflammatory bowel diseaseVedolizumabInternal medicineUstekinumabmedicineHumansGastritis HypertrophicColectomybusiness.industryGeneral Medicinemedicine.diseaseUlcerative colitisInfliximabInfliximabMénétrier's diseaseColitis UlcerativeUstekinumabbusinessRare diseasemedicine.drugdrugs: gastrointestinal system; gastroenterology; inflammatory bowel disease
researchProduct

Resolution of Ménétrier’s Disease after<i> Helicobacter pylori</i> Eradicating Therapy

2001

Some cases of Ménétrier’s disease associated with <i>Helicobacter pylori</i> (HP) have recently been reported in the literature. We report here the case of a 51-year-old man with a diagnosis of Ménétrier’s disease who had previously been unsuccessfully treated with H<sub>2</sub> antagonists. A subsequent demonstration of HP infection led us to treat the patient with an eradicating therapy which prompted complete regression of clinical symptoms, resolution of the gastric endoscopic picture, and absence of HP on gastric histology. This result, in accordance with others in the literature, indicates an eventual association of HP infection with Ménétrier’s disease and tha…

medicine.medical_specialtybiologybusiness.industryGastroenterologyChronic gastritisGeneral MedicineDiseaseHelicobacter pylorimedicine.diseasebiology.organism_classificationGastroenterologyMénétrier's diseaseInternal medicineMedicinebusinessDigestive Diseases
researchProduct